Icra sees pharma industry growth tapering to 7-10% over FY18-FY20Post published:July 4, 2017Post category:Industry NewsThe Indian pharma industry is likely to witness a slowdown in growth because of pricing pressure and regulatory interventions in the US, according to an Icra report Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostIndoStar Capital close to acquiring ICICI Home Finance Next PostGST rates: Footwear to cost more as firms look to increase prices by 5-7% You Might Also Like RBI tells Catholic Syrian Bank to settle valuation issues with Prem Watsa’s Fairfax May 31, 2017 Siemens announces addition of four devices to Simatic ET 200SP motor starters portfolio November 26, 2019 Madhya Pradesh seeks to quash Goldman-backed solar project September 9, 2017
Siemens announces addition of four devices to Simatic ET 200SP motor starters portfolio November 26, 2019